Contact Us Careers Register
Coherent Market Insights

Deep Brain Stimulation Devices Market for Parkinson’s Disease is expected to surpass US$ 6,234.3 Mn by The End of 2028

Deep Brain Stimulation Devices Market for Parkinson’s Disease is expected to surpass US$ 6,234.3 Mn by The End of 2028 - Coherent Market Insights

Publish In : Sep 14, 2021

Report ID : CMI4627

Category : Medical Devices

Deep Brain Stimulation Devices Market for Parkinson’s Disease is expected to surpass US$ 6,234.3 Mn by The End of 2028

Deep brain stimulation devices are used in the last stage of disease associated with increased complications. Deep brain stimulation therapy is a proven-effective advanced surgical option used to treat mild to severe Parkinson’s disease symptoms.

Market Statistics:

Global deep brain stimulation devices market for Parkinson’s disease is expected to surpass US$ 6,234.3 Mn in terms of value by the end of 2028.

Global Deep Brain Stimulation Devices Market for Parkinson’s Disease: Drivers

Approval and launch of new products is expected to propel growth of the global deep brain stimulation devices market for Parkinson’s disease over the forecast period. For instance, in June 2020, The U.S. Food and Drug Administration (FDA) approved Medtronic Plc’s Percept PC Neurostimulator designed to allow for a more individualized use of deep brain stimulation therapy in people with Parkinson’s disease and related disorders.

Global Deep Brain Stimulation Devices Market for Parkinson’s Disease: Opportunities

R&D in deep brain stimulation is expected to offer lucrative growth opportunities for players in the global deep brain stimulation devices market for Parkinson’s disease. For instance, according to a study published in July 2020, in Neurology, the medical journal of the American Academy of Neurology, deep brain stimulation may not increase the risk of developing dementia in people with Parkinson’s disease.

Global Deep Brain Stimulation Devices Market for Parkinson’s Disease: Recent Developments

The technological advancement for developing and improving deep brain stimulation devices can be attributed to the growth of deep brain stimulation devices market. For instance, in September 2021, the Mayo Clinic and the Google Research Brain Team, developed a new type of artificial intelligence (AI) algorithm for accurately determining the interaction between different regions of the brain. This will help in improving the way brain stimulation devices used for treating Parkinson’s disease.

In addition, the increasing product approvals is further boosting the market growth. For instance, in January 2020, Abbott received the U.S. Food and Drug Administration (FDA) approval for Infinity Deep Brain Stimulation (DBS) system for including targeted area of the brain called the internal globus pallidus (GPi). This area plays an integral role in motor function and can be targeted with Deep Brain Stimulation (DBS) for improving the symptoms of Parkinson's disease.

Similarly, in January 2021, Boston Scientific Corporation received U.S. FDA approval for Vercise Genus Deep Brain Stimulation (DBS) System. It is used for treating Parkinson's disease by delivering targeted electrical stimulation via surgically-implanted leads in the brain. Hence, such technological innovations will help in improving better treatment for Parkinson’s disease which in turn will drive the market growth over the forecast period.

Global Deep Brain Stimulation Devices Market for Parkinson’s Disease: Restraints

Risks involved in deep brain stimulation devices for Parkinson’s disease are expected to hinder growth of the global deep brain stimulation devices market for Parkinson’s disease. Deep brain stimulation for Parkinson’s disease involves some complications post-surgery such as cerebral hemorrhage, paralysis, stroke, speech impairment, and other complications.

To know the latest trends and insights prevalent in the Deep Brain Stimulation Devices Market for Parkinson’s Disease, click the link below:

https://www.coherentmarketinsights.com/market-insight/deep-brain-stimulation-devices-market-for-parkinsons-disease-4627

Global Deep Brain Stimulation Devices Market for Parkinson’s Disease - Impact of Coronavirus (Covid-19) Pandemic

People suffering from Parkinson's disease are not at a higher risk of contracting COVID-19. However, people suffering from Parkinson's disease may witness hardships in treatment if contracted with the infection. Some studies have also reported evidence for direct/indirect effects of SARS-CoV-2 on motor/non-motor symptoms of Parkinson's disease. Although extremely rare, Parkinson's-like symptoms have occurred in a few people with COVID-19. Moreover, without the vaccine, people suffering from Parkinson's disease are at high risk of complications and death.

 Key Takeaways:

  • The global deep brain stimulation devices market for Parkinson’s disease was valued at US$ 3,324.5 Mn in 2020 and is forecast to reach a value of US$ 6,234.3 Mn by 2028 at a CAGR of 8.3% between 2021 and 2028.
  • The dual channel segment was valued US$ 1,057.2 Mn in 2020 and is expected to witness a CAGR of 7.8% over the forecast period.

Market Trends

R&D in deep brain stimulation is expected to boost growth of the global deep brain stimulation devices market for Parkinson’s disease. For instance, the study, “Magnetoelectric Materials for Miniature, Wireless Neural Stimulation at Therapeutic Frequencies,” published in June 2020, in the journal Neuron, proposed a miniature, wireless, and magnetically powered neural stimulator for deep brain stimulation therapy for Parkinson’s disease.

Deep brain stimulation is beneficial for patients with late‐stage Parkinson’s disease. For instance, the study, “Should We Consider Deep Brain Stimulation Discontinuation in Late‐Stage Parkinson’s Disease?” published in May 2020, in the journal Movement Disorders, most people with late-stage Parkinson’s disease demonstrated benefit from continued treatment with subthalamic deep brain stimulation.

Global Deep Brain Stimulation Devices Market for Parkinson’s Disease: Competitive Landscape   

Major players operating in the global deep brain stimulation devices market for Parkinson’s disease include, Boston Scientific Corporation, MEDTRONIC, Inc., St Jude Medical, Inc., Sapiens Neuro, and Aleva Neurotherapeutics SA.

Global Deep Brain Stimulation Devices Market for Parkinson’s Disease: Key Developments

November 2019: Medtronic, Plc announced that its Activa patient programmer technology for deep brain stimulation therapy is now available to U.S. patients with Parkinson’s disease and other movement disorders.

ABOUT US:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

CONTACT US:

Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

PHONE:

UK: +44-203-957-8553 / +44-203-949-5508

US: +1-252-477-1362

AUS: +61-8-7924-7805

INDIA: +91-848-285-0837

Email: [email protected]

Follow Us: LinkedIn | Twitter

Need more?

Speak to our analyst to understand how this research was put together
Add more segments or countries to the scope as part of free customization
Understand how this report can have a direct impact on your revenue

  • Supplier Analysis
  • Value Chain Analysis
  • Demand Analysis
  • Customer Intelligence
  • Trade Analysis
  • Pricing Analysis

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports


Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Created billion dollars of revenue impact on thousands of clients

trusted clients logo

LogoCredibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

Reliability and Reputation

860519526

Reliability and Reputation
ISO 9001:2015

9001:2015

ISO 27001:2022

27001:2022

Reliability and Reputation
Reliability and Reputation
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.
Enquiry Icon Contact Us